Pelvic floor physical therapy in the treatment of chronic anal fissure (PAF trial): quality of life outcome.

Authors:
van Reijn-Baggen DA; Elzevier HW; Braak JPBM; Putter H; Pelger RCM and 1 more

Journal:
Tech Coloproctol

Publication Year: 2022

DOI:
10.1007/s10151-022-02741-7

PMCID:
PMC9753858

PMID:
36520243

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Tech Coloproctol

Abbreviation: Tech Coloproctol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Liposomal bupivacaine versus conventional anesthetic or placebo for hemorrhoidectomy: a systematic …
Solis-Pazmino P; Figueroa L; La K and 6 more (2024) - Transparency Score: 5/6
Robotic surgery for bowel endometriosis: a multidisciplinary management of a complex entity.
Piozzi GN; Burea V; Duhoky R and 5 more (2024) - Transparency Score: 3/6
Acute diverticulitis in immunocompromised patients: evidence from an international multicenter obse…
Tartaglia D; Cremonini C; Annunziata E and 8 more (2023) - Transparency Score: 4/6
An updated evaluation of the implementation of the sigmoid take-off landmark 1 year after the offic…
Hazen SJA; Sluckin TC; Horsthuis K and 5 more (2023) - Transparency Score: 3/6
Clinical characteristics of phenotypes of fecal incontinence.
Knol ME; Bastiaannet E; DeRuiter MC and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare that they have neither competing interests nor conflict of interest. Conflict of interest The authors declare that they have neither competing interests nor conflict of interest."

Evidence found in paper:

"Funding No funding of the study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025